Oncology studies dominate the clinical trial landscape; and for the millions of patients each year facing a cancer diagnosis, the search for answers is unbearable. While advancements in oncology clinical research bring hope to patients, they present many challenges to drug developers, including:

  • Complexity of innovative trial designs
  • Enrollment challenges that hinder diversity and inclusion goals
  • Intense competition for qualified sites and patients
  • Higher data volume and collection requirements compared to trials in other therapeutic areas
  • Changing standards of care and clinical strategies

To navigate these complexities, you need a clinical development partner and an experienced contract research organization. DP Clinical Project Managers and clinical teams have extensive experience in oncology clinical trial execution. We have performed Phase II-III oncology studies ranging in size from 1-40 sites and 15-500 patients and know how to successfully enroll and retain this oftentimes difficult patient population.

DP Clinical’s oncology experience includes the following indications:

  • Appetite Stimulant
  • Autoimmune Hemolytic Anemia (AIHA)
  • Basal Cell Carcinoma
  • Cancer-Associated Pain
  • Cholangiocarcinoma
  • Glioblastoma
  • Graft vs. Host
  • Hodgkin’s Disease
  • Kaposi’s Sarcoma
  • LeukemiaAcute Myeloid
  • Malignant Solid Tumors
  • Metastatic Pancreatic Adenocarcinoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome (MDS)
  • Osteosarcoma
  • Ovarian Cancer
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Prostate Cancer
  • Refractory Solid Tumors